Osteoarthritis Trial, Recruiting NCT07532070 Sponsor: University of Sydney Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07532070
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who have ongoing lower back pain, have sought or seriously thought about seeking care from a doctor or specialist for it in the past 6 weeks, and find it at least moderately interferes with work or daily activities (including housework)
  • OR people aged 45 or older who have hip or knee joint pain that comes on with activity, with no morning stiffness in those joints, or morning stiffness that lasts 30 minutes or less
  • People whose average pain over the past week has been rated at least 4 out of 10 on a pain scale (where 0 means no pain and 10 means the worst pain possible)
  • People who score 11 or higher on a standard sleep difficulty questionnaire called the Insomnia Severity Index
  • People who have access to a computer, laptop, or tablet with internet, suitable for video calls
  • People who are willing and able to take part in video consultations
  • For people being recruited in the United States: people who are covered under the Military Health System

Who may not be able to join:

  • People who are already doing more than 120 minutes per week of at least moderate-intensity physical activity and have been doing so for the past 6 months
  • People who are currently taking part in, or have taken part in, a specific type of sleep therapy called CBT-I (Cognitive Behavioural Therapy for Insomnia) in the past 6 months
  • People who show signs of significant cognitive (thinking or memory) difficulties, based on a standard screening test (confirm with trial site)
  • People who have had an injection of any substance into the area of pain being studied in the past 3 months
  • People who are waiting for, or planning to have, an injection into the area of pain being studied within the next 12 months
  • People who have had surgery in the past 12 months, or who are waiting for or planning surgery in the next 12 months
  • People who have a neurological or whole-body condition that may affect physical function, such as Parkinson's disease, active cancer, multiple sclerosis, rheumatoid arthritis, or ankylosing spondylitis
  • People who do not pass a standard pre-exercise health screening questionnaire without first getting medical clearance to participate
  • People who are unable to give informed consent or take part in the study's procedures
  • People who are unable to speak or read English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +610433014884

Australian sites

Susan Wakil Health Building, Camperdown, New South Wales
The University of Queensland Therapies Building (84A), Brisbane, Saint Lucia

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Sydney
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇦🇺 Australia 🇺🇸 United States

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Average Pain severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov